cyclohexanol has been researched along with Cardiac Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crystal, S; Olfson, M; Sambamoorthi, U; Walkup, JT | 1 |
| Scott, JR; Taylor, D | 1 |
| Baud, FJ; Bloch, V; Deye, N; Mégarbane, B | 1 |
3 other study(ies) available for cyclohexanol and Cardiac Diseases
| Article | Year |
|---|---|
Diffusion of new generation antidepressant treatment among elderly diagnosed with depression.
Topics: Age Factors; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depression; Diabetes Mellitus; Fee-for-Service Plans; Female; Health Status; Heart Diseases; Humans; Hypertension; Male; Medicare; Monoamine Oxidase Inhibitors; Multivariate Analysis; Racial Groups; Sample Size; Sampling Studies; Selective Serotonin Reuptake Inhibitors; Sex Factors; Socioeconomic Factors; Venlafaxine Hydrochloride | 2003 |
Volte-face on venlafaxine--reasons and reflections.
Topics: Animals; Antidepressive Agents, Second-Generation; Cardiovascular Physiological Phenomena; Cause of Death; Cyclohexanols; Drug Overdose; Drug Prescriptions; Guidelines as Topic; Heart Diseases; Humans; United Kingdom; Venlafaxine Hydrochloride | 2006 |
Pharmacokinetic/pharmacodynamic modelling of cardiac toxicity in venlafaxine overdose.
Topics: Cyclohexanols; Drug Overdose; Female; Heart Diseases; Humans; Middle Aged; Models, Biological; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |